2023 Q3 Form 10-Q Financial Statement

#000164033423001569 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.010K
YoY Change -58.25%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.334K -$8.731K $9.010K
YoY Change -106.74% -196.9% -58.25%
Operating Profit -$1.334K -$389.00 -$9.010K
YoY Change -93.37% -95.68% -58.25%
Interest Expense $393.00
YoY Change -226.77%
% of Operating Profit
Other Income/Expense, Net -$393.00 -$389.00 $0.00
YoY Change 25.96%
Pretax Income -$9.010K
YoY Change -74.86%
Income Tax
% Of Pretax Income
Net Earnings -$1.727K -$9.120K -$9.010K
YoY Change -91.42% 1.22% -57.35%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$905.70
COMMON SHARES
Basic Shares Outstanding 9.948M shares 9.948M shares 9.948M shares
Diluted Shares Outstanding 9.948M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change -100.0%
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $0.00 $0.00
Receivables
Other Receivables
Total Short-Term Assets $0.00
YoY Change -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.00
YoY Change -99.15%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $24.42K
YoY Change -70.86%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $86.72K $24.52K
YoY Change 59.03% -74.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $86.72K $24.52K
Total Long-Term Liabilities $0.00
Total Liabilities $86.72K $78.99K $24.52K
YoY Change 59.04% 222.13% -74.36%
SHAREHOLDERS EQUITY
Retained Earnings -$129.6K -$121.9K -$67.40K
YoY Change 48.09% 80.82% -50.49%
Common Stock $995.00 $995.00 $995.00
YoY Change 0.0% 0.0% -2.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$86.72K -$78.99K -$24.52K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.727K -$9.120K -$9.010K
YoY Change -91.42% 1.22% -57.35%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$8.980K
YoY Change -68.92%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.980K
YoY Change -69.61%
NET CHANGE
Cash From Operating Activities -8.980K
Cash From Investing Activities
Cash From Financing Activities 8.980K
Net Change In Cash 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$8.980K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Liabilities
Liabilities
78993 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9948330 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
995 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41879 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121867 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-78993 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001794942
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9948330 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9948330 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9948330 shares
CY2021Q3 us-gaap Shares Outstanding
SharesOutstanding
10000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-237100
dei Entity Registrant Name
EntityRegistrantName
STARK FOCUS GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Address Address Line1
EntityAddressAddressLine1
38 S Federal Highway
dei Entity Address Address Line2
EntityAddressAddressLine2
#10-199
dei Entity Address City Or Town
EntityAddressCityOrTown
Dania Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33004
dei City Area Code
CityAreaCode
352
dei Local Phone Number
LocalPhoneNumber
562 - 0289
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9948330 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5967 usd
CY2023Q2 us-gaap Assets
Assets
0 usd
CY2022Q4 us-gaap Assets
Assets
5967 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
14479 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
13705 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
64514 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
47665 usd
CY2022Q4 us-gaap Liabilities
Liabilities
61370 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
995 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41879 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98277 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-55403 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5967 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8731 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9010 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22816 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12392 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
-8731 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
-9010 usd
us-gaap Operating Expenses
OperatingExpenses
-22816 usd
us-gaap Operating Expenses
OperatingExpenses
-12392 usd
CY2023Q2 us-gaap Financing Interest Expense
FinancingInterestExpense
389 usd
CY2022Q2 us-gaap Financing Interest Expense
FinancingInterestExpense
0 usd
us-gaap Financing Interest Expense
FinancingInterestExpense
774 usd
us-gaap Financing Interest Expense
FinancingInterestExpense
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-389 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-774 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9120 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9010 usd
us-gaap Net Income Loss
NetIncomeLoss
-23590 usd
us-gaap Net Income Loss
NetIncomeLoss
-12392 usd
CY2023Q2 stark Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2022Q2 stark Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
stark Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
stark Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
CY2023Q2 stark Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
9948330 shares
CY2022Q2 stark Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
9948330 shares
stark Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
9948330 shares
stark Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
9948330 shares
us-gaap Net Income Loss
NetIncomeLoss
-23590 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-12130 usd
us-gaap Net Income Loss
NetIncomeLoss
-12392 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-24522 usd
us-gaap Profit Loss
ProfitLoss
23590 usd
us-gaap Profit Loss
ProfitLoss
12392 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5967 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5963 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17623 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18355 usd
stark Payment Of Interest For Promissory Note
PaymentOfInterestForPromissoryNote
-774 usd
stark Payment Of Interest For Promissory Note
PaymentOfInterestForPromissoryNote
0 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
16849 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
18355 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17623 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18355 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2019Q3 stark Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
1 pure
CY2021Q3 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
10000 shares
CY2021Q3 us-gaap Proceeds From Securities Purchased Under Agreements To Resell
ProceedsFromSecuritiesPurchasedUnderAgreementsToResell
10000 hkd
CY2021Q3 us-gaap Shares Issued
SharesIssued
10000 shares
CY2023Q2 us-gaap Liabilities
Liabilities
78993 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p>
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
389 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
774 usd
CY2023Q2 us-gaap Loans Payable
LoansPayable
64514 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
47665 usd
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9948330 shares

Files In Submission

Name View Source Status
0001640334-23-001569-index-headers.html Edgar Link pending
0001640334-23-001569-index.html Edgar Link pending
0001640334-23-001569.txt Edgar Link pending
0001640334-23-001569-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stark-20230630.xsd Edgar Link pending
stark_10q.htm Edgar Link pending
stark_ex311.htm Edgar Link pending
stark_ex321.htm Edgar Link pending
stark-20230630_def.xml Edgar Link unprocessable
stark-20230630_pre.xml Edgar Link unprocessable
stark-20230630_cal.xml Edgar Link unprocessable
stark-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
stark_10q_htm.xml Edgar Link completed